Evaluation of mHealth Intervention to Promote HIV Prevention and Overcome Stigma Among Transgender Women (EMPOW.HER)
Recruiting · NCT07509827 · Interventional (participants receive a specific treatment) · Lead sponsor: Institute of HIV Research and Innovation Foundation, Thailand
View the official record on ClinicalTrials.gov →Interventions studied
FRESH + SPCMobile Healthy Choices (mHC)+SPCmHC + FRESH + SPC
What this trial is about
This study aims to develop and evaluate a multi-component mHealth intervention (mHC and FRESH) to reduce HIV-related and intersectional stigma and improve PrEP use among HIV-negative young transgender women (TGW) in Thailand.
Who can take part
Age range
18 Years to 29 Years
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age 18-29 years
- Male sex at birth
- Self-identify as transgender woman/female spectrum
- HIV-negative (laboratory confirmed)
- Recent condomless sex
- Able to understand Thai
- Not on PrEP or poorly adherent (≤3 pills/week)
Exclusion criteria
- Serious cognitive or psychiatric condition affecting consent
- Active suicidal ideation or major mental illness
- Medical contraindications to PrEP
- Enrolled in another HIV intervention study
Where it is running
3 locations listed.
- Rainbow Sky Association of Thailand (RSAT) - Bangkok, Bangkapi, Thailand
- The Service Workers In Group Foundation (SWING) - Bangkok, Building 3, Patpong, Surawong Road, Thailand
- Institute of HIV Research and Innovation (IHRI) - Bangkok, Pathumwan, Thailand